What comes after macrolides and other motilin stimulants?
作者信息
Tack J, Peeters T
机构信息
Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, Belgium.
出版信息
Gut. 2001 Sep;49(3):317-8. doi: 10.1136/gut.49.3.317.
Abstract
摘要
相似文献
1
What comes after macrolides and other motilin stimulants?大环内酯类药物和其他胃动素兴奋剂之后是什么？
Gut. 2001 Sep;49(3):317-8. doi: 10.1136/gut.49.3.317.
2
Gastroduodenal motility disorders.胃十二指肠动力障碍
Curr Opin Gastroenterol. 2018 Nov;34(6):428-435. doi: 10.1097/MOG.0000000000000473.
3
New developments in the treatment of gastroparesis and functional dyspepsia.胃轻瘫和功能性消化不良治疗的新进展。
Curr Opin Pharmacol. 2018 Dec;43:111-117. doi: 10.1016/j.coph.2018.08.015. Epub 2018 Sep 21.
4
Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis.STW 5（伊贝戈斯特）对功能性消化不良和胃轻瘫患者的临床疗效并非基于胃排空加速。
Neurogastroenterol Motil. 2009 Jun;21(6):632-8, e25. doi: 10.1111/j.1365-2982.2008.01249.x. Epub 2009 Feb 6.
5
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.胃动素受体激动剂（ABT-229）对1型糖尿病患者上消化道症状的影响：一项随机、双盲、安慰剂对照试验
Gut. 2001 Sep;49(3):395-401. doi: 10.1136/gut.49.3.395.
6
Gastroparesis: separate entity or just a part of dyspepsia?胃轻瘫：独立实体还是消化不良的一部分？
Gut. 2014 Dec;63(12):1972-8. doi: 10.1136/gutjnl-2013-306084. Epub 2014 Sep 26.
7
Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment.幽门螺杆菌治疗后患者症状及胃排空情况的变化。
World J Gastroenterol. 2016 May 14;22(18):4585-93. doi: 10.3748/wjg.v22.i18.4585.
8
Pharmacotherapy of gastroparesis.
Expert Opin Pharmacother. 2000 Jul;1(5):881-7. doi: 10.1517/14656566.1.5.881.
9
Metoclopramide-stimulated gastric emptying scintigraphy: does it predict symptom response to prokinetic therapy in chronic gastroparesis?甲氧氯普胺刺激胃排空闪烁扫描：它能预测慢性胃轻瘫患者对促动力治疗的症状反应吗？
Am J Gastroenterol. 2002 Sep;97(9):2474-6. doi: 10.1111/j.1572-0241.2002.06014.x.
10
Future directions in the treatment of gastroparesis.胃轻瘫治疗的未来方向。
Gastroenterol Clin North Am. 2015 Mar;44(1):185-9. doi: 10.1016/j.gtc.2014.11.014. Epub 2014 Dec 20.
引用本文的文献
1
The influence of herbal medicine on serum motilin and its effect on human and animal model: a systematic review.草药对血清胃动素的影响及其对人和动物模型的作用：一项系统评价。
Front Pharmacol. 2023 Dec 14;14:1286333. doi: 10.3389/fphar.2023.1286333. eCollection 2023.
2
The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review.胃肠肽在功能性消化不良和胃轻瘫中的作用：一项系统评价
Front Psychiatry. 2020 Mar 18;11:172. doi: 10.3389/fpsyt.2020.00172. eCollection 2020.
3
Prokinetics in the Management of Functional Gastrointestinal Disorders.促动力药在功能性胃肠病管理中的应用
Curr Gastroenterol Rep. 2017 Sep 8;19(10):53. doi: 10.1007/s11894-017-0593-6.
4
Prokinetics in the Management of Functional Gastrointestinal Disorders.促动力药在功能性胃肠病管理中的应用
J Neurogastroenterol Motil. 2015 Jul 30;21(3):330-6. doi: 10.5056/jnm15094.
5
Current management of functional dyspepsia: impact of Rome III subdivision.功能性消化不良的当前管理：罗马III分类的影响
Ann Gastroenterol. 2012;25(2):96-99.
6
Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.胃动素：对胃肠道神经药理学和胃动素受体激动剂治疗用途的新认识。
Br J Pharmacol. 2013 Dec;170(7):1323-32. doi: 10.1111/bph.12075.
7
The migrating motor complex: control mechanisms and its role in health and disease.移行性复合运动：控制机制及其在健康和疾病中的作用。
Nat Rev Gastroenterol Hepatol. 2012 Mar 27;9(5):271-85. doi: 10.1038/nrgastro.2012.57.
8
The roles of motilin and ghrelin in gastrointestinal motility.胃动素和胃饥饿素在胃肠动力中的作用。
Int J Pept. 2010;2010. doi: 10.1155/2010/820794. Epub 2010 Feb 3.
9
Diabetic gastroparesis: diagnosis and management.糖尿病性胃轻瘫：诊断与管理
Drugs. 2009 May 29;69(8):971-86. doi: 10.2165/00003495-200969080-00003.
10
Risk of aspiration in patients on enteral nutrition: frequency, relevance, relation to pneumonia, risk factors, and strategies for risk reduction.肠内营养患者的误吸风险：发生率、相关性、与肺炎的关系、危险因素及降低风险的策略。
Curr Gastroenterol Rep. 2007 Aug;9(4):338-44. doi: 10.1007/s11894-007-0039-7.
本文引用的文献
1
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.胃动素受体激动剂（ABT-229）对1型糖尿病患者上消化道症状的影响：一项随机、双盲、安慰剂对照试验
Gut. 2001 Sep;49(3):395-401. doi: 10.1136/gut.49.3.395.
2
Perception of changes in wall tension of the proximal stomach in humans.人类对近端胃壁张力变化的感知。
Gut. 2001 Aug;49(2):203-8. doi: 10.1136/gut.49.2.203.
3
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.胃动素受体激动剂（ABT - 229）对有无胃排空延迟的功能性消化不良患者缓解症状的无效性：一项随机双盲安慰剂对照试验。
Aliment Pharmacol Ther. 2000 Dec;14(12):1653-61. doi: 10.1046/j.1365-2036.2000.00868.x.
4
Z-338, a newly synthetized carboxyamide derivative, stimulates gastric motility through enhancing the excitatory neurotransmission.Z-338是一种新合成的羧酰胺衍生物，通过增强兴奋性神经传递来刺激胃动力。
J Smooth Muscle Res. 2000 Apr;36(2):69-81. doi: 10.1540/jsmr.36.69.
5
Tegaserod.替加色罗
Drugs. 1999 Sep;58(3):491-6; discussion 497-8. doi: 10.2165/00003495-199958030-00013.
6
Receptor for motilin identified in the human gastrointestinal system.在人类胃肠系统中鉴定出胃动素受体。
Science. 1999 Jun 25;284(5423):2184-8. doi: 10.1126/science.284.5423.2184.
7
Gastric wall tension determines perception of gastric distention.胃壁张力决定胃扩张的感知。
Gastroenterology. 1999 May;116(5):1035-42. doi: 10.1016/s0016-5085(99)70006-5.
8
Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans.红霉素对人体胃窦运动效应涉及两条不同途径。
Gut. 1998 Sep;43(3):395-400. doi: 10.1136/gut.43.3.395.
9
Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans.内源性胆囊收缩素对人体餐后食管下括约肌功能和胃底张力的影响
Am J Physiol. 1998 Dec;275(6):G1266-73. doi: 10.1152/ajpgi.1998.275.6.G1266.
10
Role of impaired gastric accommodation to a meal in functional dyspepsia.胃对进餐的适应性受损在功能性消化不良中的作用。
Gastroenterology. 1998 Dec;115(6):1346-52. doi: 10.1016/s0016-5085(98)70012-5.
Zotero 插件